Pliant Therapeutics, Inc. (PLRX)

Pliant Therapeutics, Inc. (PLRX) is a healthcare company (biotechnology) based in the United States. The share price is $0.66, down 4.76% on the day, which values the company at $40.93M. Price as of 18 Nov 2026, 11:43 UTC, from Yahoo Finance.

Key facts

Share price
$0.66−4.76% today
Market value
$40.93M
200-week average
$9.7293% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Pliant Therapeutics, Inc. in more detail

PLRX trades at -0.5× next year's expected earnings. It sits 93% below its 200-week average of $9.72.

In its favour: More cash than debt. Worth checking: Weak Piotroski score; Share count keeps rising.

Pliant Therapeutics, Inc. (PLRX): questions and answers

What is Pliant Therapeutics, Inc.'s market cap?

Pliant Therapeutics, Inc. is valued at $40.93M at a share price of $0.66.

Is PLRX above its 200-week moving average?

No. PLRX is 93.2% below its 200-week average of $9.72. Long-term investors watch that line because strong companies rarely trade below it for long.

Does PLRX pay a dividend?

Pliant Therapeutics, Inc. does not currently pay a regular dividend.

Cite this page

Funkfolio, “Pliant Therapeutics, Inc. (PLRX) stock: price, valuation and fundamentals”, data as of 18 November 2026. https://funkfolio.com/stock/PLRX

Underlying data: Yahoo Finance; company filings with the SEC.